LEADER 01345oam  2200421   450 
001 9910707259803321
005 20160613083250.0
035   $a(CKB)5470000002462909
035   $a(OCoLC)951607066
035   $a(OCoLC)995470000002462909
035   $a(EXLCZ)995470000002462909
100   $a20160613d2014      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aUpdate $eMedicare payments for end stage renal disease drugs
210  1$aWashington, DC :$cDepartment of Health and Human Services, Office of Inspector General,$d2014.
215   $a1 online resource (36 pages) $cillustrations
300   $aTitle from title screen (viewed June 3, 2016).
300   $a"March 2014."
300   $a"OEI-03-12-00550."
320   $aIncludes bibliographical references.
517   $aUpdate 
606   $aMedicare$xClaims administration
606   $aChronic renal failure$xTreatment$zUnited States$xFinance
606   $aDrugs$zUnited States$xCosts
615  0$aMedicare$xClaims administration.
615  0$aChronic renal failure$xTreatment$xFinance.
615  0$aDrugs$xCosts.
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910707259803321
996   $aUpdate$92038694
997   $aUNINA